Personalized Treatment of Refractory BPPV

NCT ID: NCT06725966

Last Updated: 2024-12-10

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 54 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-07-01
• Study Completion Date: 2026-12-31

Brief Summary

Background: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo, often effectively treated with standard canalith repositioning maneuvers (CRMs). However, approximately 12.5% of cases remain refractory, leading to persistent symptoms and increased healthcare burden. Variations in the anatomical orientation of the semicircular canals (SCCs) may explain the resistance to conventional maneuvers. This study explores a personalized medicine approach, utilizing computational fluid dynamics (CFD) based on MRI reconstructions to tailor CRMs with the help of mechanical rotation chair according to individual inner ear anatomy.

Methods: The investigators conducted a randomized, multicenter, open-label study targeting patients with refractory posterior canal BPPV. Participants were allocated to either a control group (receiving repeated standard CRMs and Brandt-Daroff exercises) or an intervention group (receiving personalized CRMs based on CFD simulations derived from MRI scans). The intervention group's maneuvers were executed using a mechanical rotational chair designed for precise angulation. Primary outcomes included resolution of nystagmus and vertigo symptoms, while secondary outcomes measured the reduction in healthcare visits and improved quality of life (Dizziness Handicap Inventory score).

Detailed Description

1. STUDY DESIGN This is an experimental, multicenter, open-label, randomized study (using balanced block randomization) with two parallel arms. The study targets patients with a definitive diagnosis of refractory posterior semicircular canal BPPV (BPPVp).

2. STUDY PARTICIPANTS Study Period: From January 1, 2024, to December 31, 2026. Study Population: Patients diagnosed with BPPV. Target Population: Individuals >18 years of age, of both sexes, diagnosed with unilateral refractory BPPVp, from three Health Areas. Participants will be selected from patients attending the Otoneurology Unit of the Otolaryngology Departments of these three University Hospital Complexes.

To confirm the diagnosis and rule out other potential causes, all participants will undergo a complete otoneurological evaluation, including:

• Otoscopy.
• Basic neurological examination.
• Observation of spontaneous nystagmus (with and without gaze fixation).
• Clinical head impulse test (vHIT), including video-assisted evaluation.
• Positional tests (DHT, McClure test, and head hyperextension), with videonystagmographic recording.
• Pure-tone audiometry. In cases of refractory BPPV (lack of resolution after three therapeutic maneuvers), a magnetic resonance imaging (MRI) scan of the inner ears and posterior cranial fossa will be requested to rule out central neurological causes.

3. RANDOMIZATION

Pre-selection Visit (Visit -1): Participants will undergo a comprehensive vestibular assessment to identify candidates with refractory BPPVp. The following tests will be included:

• Video-assisted head impulse test (vHIT) to assess for other vestibular pathologies.
• Dix-Hallpike test (DHT) to confirm the diagnosis of BPPVp.
• McClure test to exclude horizontal canal BPPV.
• Head hyperextension test to exclude superior canal BPPV.
• Dizziness Handicap Inventory (DHI) questionnaire adapted to Spanish, assessing perceived disability due to vertigo.

For posterior canal BPPV, it will be verified in the medical record that three repositioning maneuvers (Epley and/or Semont) were performed without symptom resolution.

Eligible participants will be given a detailed explanation of the study objectives and procedures, and will receive the approved Patient Information Sheet (PIS) to provide informed consent.

4. RANDOMIZATION PROCESS

Visit 0 (Randomization Visit): After obtaining consent, participants will be randomized to one of the following study arms:

• Control Group: Participants will be advised to perform Brandt-Daroff exercises at home twice daily for 8 weeks. An MRI of the inner ear and posterior cranial fossa will also be requested. If the exercises are ineffective, repositioning maneuvers using a mechanized chair will be repeated biweekly until symptom resolution.

• Study Group: Participants will perform Brandt-Daroff exercises at home twice daily for 8 weeks. An MRI will be conducted, and based on the images, a personalized mathematical model will be created to modify the angles of the repositioning maneuver. If the exercises are ineffective, the personalized maneuver will be performed using a mechanized chair.

A balanced block randomization sequence with block size n=10 will be generated by a member of the research team.

5. DATA COLLECTION

Even if intermediate visits are necessary, the following study visits will be conducted according to the protocol (with data recording):

• Visit 1 (Eight Weeks After Inclusion):

• The Dix-Hallpike Test (DHT) will be performed with videonystagmographic recording. If positive:

• In the control group, the conventional Epley maneuver will be repeated using a mechanized chair.
• In the study group, a personalized Epley maneuver will be performed using a mechanized chair.
• Visit 2 (Ten Weeks After Inclusion):

• The DHT will be repeated with videonystagmographic recording. If positive:
• In the control group, the conventional Epley maneuver will be repeated using a mechanized chair.
• In the study group, the personalized Epley maneuver will be repeated using a mechanized chair.

These maneuvers (conventional for the control group and personalized for the study group) will be repeated every two weeks until resolution of symptoms (or up to a maximum of 8 repetitions).

• Visit 3 (Six Months After Inclusion):

• The following variables will be recorded:

• Dix-Hallpike Test (DHT) results (negative or positive).
• Dizziness Handicap Inventory (DHI) score.
• Number of consultations required for resolution.

5. MATHEMATICAL STUDY A 3D model of the affected membranous labyrinth will be reconstructed based on MRI imaging. An analysis of the planes on which the semicircular canals rest will be performed, and the geometric model will be adapted for subsequent numerical simulation. The computational study, carried out using Computational Fluid Dynamics (CFD) techniques, will involve combining the dynamics of the endolymph within the labyrinth and the particle dynamics of the free otoliths.

Mathematically, the Navier-Stokes equations will be coupled with a discrete particle model sensitive to gravity and the fluid forces. This will allow for the determination of the velocity distribution of the endolymph, the pressures exerted on the labyrinth walls, as well as the timing and positions of the otoliths during the personalized Epley maneuver.

6. DATA ANALYSIS Demographic data and patient characteristics will be described globally and by relevant covariables.

Continuous outcomes will be summarized using mean, median, standard deviation (SD), and interquartile range (P25, P75). For categorical outcomes, the number and percentage of patients in each category will be reported. Statistical analyses will be based on the full analysis set (FAS), which includes all randomized participants who provided informed consent and met all inclusion criteria without any exclusion criteria.

7. STUDY LIMITATIONS, DATA BIASES, AND MITIGATION STRATEGIES Despite being an open-label study, the potential bias introduced is minimal, as both the maneuvers and outcome evaluation are performed by the same person. The primary outcome (resolution of nystagmus) is assessed objectively through videonystagmography, which does not require interpretation by the evaluator.

There is a risk of patient dropout during the eight-week period of Brandt-Daroff exercises prior to the personalized maneuver. To mitigate this risk, patient adherence will be closely monitored and encouraged.

Since patients will be recruited from three different hospitals, there may be diagnostic biases depending on the evaluator. However, all intervention maneuvers (both personalized and conventional) will be conducted at a single center, where a diagnostic reevaluation will be performed prior to intervention to confirm that the BPPV remains unresolved and exclusively affects the posterior canal.

8. SAMPLE SIZE AND CALCULATION METHODOLOGY To estimate the sample size, the investigators assume that approximately 25% of patients with refractory BPPVp may be cured through repeated maneuvers or Brandt-Daroff exercises (control group). A significant difference of 50% in the study group (i.e., a 75% efficacy rate for symptom resolution) is considered clinically meaningful. With a 95% confidence level (1-α) and 95% statistical power for a two-tailed hypothesis test, a sample size of 23 participants per arm is required. Thus, the estimated total sample size is 46 individuals, increased to 54 (27 per group) to account for a 15% anticipated dropout rate.

Conditions

Benign Paroxysmal Positional Vertigo; Personalized Medicine

Keywords

BPPV; Benign paroxysmal positional vertigo; Computational fluid dynamics; MRI; Canalith repositioning maneuvers; Mechanical rotation chair

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Conventional Epley maneuver

Participants will be advised to perform Brandt-Daroff exercises at home twice daily for 8 weeks. An MRI of the inner ear and posterior cranial fossa will also be requested. If the exercises are ineffective, repositioning maneuvers using a mechanized chair will be repeated biweekly until symptom resolution.

Group Type: ACTIVE_COMPARATOR

Conventional Epley maneuver

Intervention Type: PROCEDURE

Epley maneuver using a mechanized chair

Personalized Epley maneuver

Participants will perform Brandt-Daroff exercises at home twice daily for 8 weeks. An MRI will be conducted, and based on the images, a personalized mathematical model will be created to modify the angles of the repositioning maneuver. If the exercises are ineffective, the personalized maneuver will be performed using a mechanized chair.

Group Type: EXPERIMENTAL

Personalized Epley maneuver

Intervention Type: PROCEDURE

Personalized Epley maneuver, using a mechanized chair

Interventions

Conventional Epley maneuver

Epley maneuver using a mechanized chair

Intervention Type: PROCEDURE

Personalized Epley maneuver

Personalized Epley maneuver, using a mechanized chair

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• A. Diagnosed with BPPVp according to the Barany Society criteria:

1. Recurrent episodes of vertigo or positional instability, triggered by lying down or turning the head in the supine position.

2. Episodes lasting less than 1 minute.

3. Positional nystagmus observed after a latency period during the Dix-Hallpike test (DHT), with an upward vertical component and a torsional component (clockwise on the left side and counterclockwise on the right).

4. Symptoms not explained by any other cause.

AND

• B. Refractory to otolith repositioning maneuvers (Epley and/or Semont maneuvers), with persistence of symptoms after three attempts.

Exclusion Criteria

• Cognitive impairment that prevents understanding of their condition and the required procedures.
• Pathological conditions that hinder the execution of the maneuvers.
• BPPV involving canals other than the posterior canal or bilateral posterior canal involvement.
• Low educational level, which may impede understanding of the procedures and informed consent.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 100 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Instituto de Salud Carlos III

OTHER_GOV

Sponsor Role: collaborator

European Union

OTHER

Sponsor Role: collaborator

Hospital Clinico Universitario de Santiago

OTHER

Sponsor Role: lead

Responsible Party

Andrés Soto-Varela

Professor and Chairman

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Andrés Soto-Varela, Prof, PhD

Role: PRINCIPAL_INVESTIGATOR

Complexo Hospitalario Universitario de Santiago

Locations

Hospital Clínico Universitario

Santiago de Compostela, A Coruña, Spain

Site Status: RECRUITING

Countries

Spain

Central Contacts

Andrés Soto-Varela, Prof, PhD

Role: CONTACT

Phone: +34981951157

Email: andres.soto.varela@sergas.es

Ismael Arán-Tapia, PhD

Role: CONTACT

Phone: +34663654574

Email: ismaelaran.tapia@usc.es

Facility Contacts

Andrés Soto-Varela, PhD

Role: primary

References

Rossi-Izquierdo M, Santos-Perez S, Aran-Tapia I, Blanco-Ulla M, Aran-Gonzalez I, Vaamonde-Sanchez-Andrade I, Franco-Gutierrez V, Perez-Munuzuri V, Munuzuri AP, Soto-Varela A. Personalized medicine to treat refractory benign paroxysmal positional vertigo, through computational fluid dynamics analysis from magnetic resonance image reconstructions. Front Neurol. 2025 Mar 11;16:1561356. doi: 10.3389/fneur.2025.1561356. eCollection 2025.

Reference Type: DERIVED

PMID: 40134694 (View on PubMed)

Other Identifiers

PI23/0024

Identifier Type: -

Identifier Source: org_study_id